BRIDGEBIO PHARMA, INC., 8-K filed on 2/24/2026
Current report filing
v3.25.4
Document and Entity Information
Feb. 24, 2026
Cover [Abstract]  
Document Type 8-K
Period End Date Feb. 24, 2026
Registrant Name BridgeBio Pharma, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38959
Entity Tax Identification Number 84-1850815
Entity Address, Address Line One 3160 Porter Dr., Suite 250
Entity Address, City or Town Palo Alto
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94304
City Area Code 650
Local Phone Number 391-9740
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol BBIO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
CIK 0001743881
Amendment false